242 related articles for article (PubMed ID: 30122782)
41. Urinary function and quality of life after radiotherapy for prostate cancer in patients with prior history of surgical treatment for benign prostatic hyperplasia.
Guilhen M; Hennequin C; Ouzaid I; Fumagalli I; Martin V; Guillerm S; Mongiat-Artus P; Ravery V; Desgrandchamps F; Quéro L
Radiat Oncol; 2018 Oct; 13(1):209. PubMed ID: 30355359
[TBL] [Abstract][Full Text] [Related]
42. Holmium:YAG transurethral incision versus laser photoselective vaporization for benign prostatic hyperplasia in a small prostate.
Elshal AM; Elkoushy MA; Elmansy HM; Sampalis J; Elhilali MM
J Urol; 2014 Jan; 191(1):148-54. PubMed ID: 23845460
[TBL] [Abstract][Full Text] [Related]
43. A 10-year follow-up after transurethral resection of the prostate, contact laser prostatectomy and electrovaporization in men with benign prostatic hyperplasia; long-term results of a randomized controlled trial.
Hoekstra RJ; Van Melick HH; Kok ET; Ruud Bosch JL
BJU Int; 2010 Sep; 106(6):822-6. PubMed ID: 20184573
[TBL] [Abstract][Full Text] [Related]
44. Prostatic cystadenoma presenting as a large multilocular mass.
Matsumoto K; Egawa S; Iwabuchi K; Baba S
Int J Urol; 2002 Jul; 9(7):410-2. PubMed ID: 12165026
[TBL] [Abstract][Full Text] [Related]
45. Long-term clinical outcome of diagnostic transurethral resection of the prostate in patients with elevated prostate-specific antigen level and minor lower urinary tract symptoms.
van Renterghem K; van Koeveringe G; Achten R; van Kerrebroeck P
Urol Int; 2009; 83(1):60-5. PubMed ID: 19641361
[TBL] [Abstract][Full Text] [Related]
46. Prospective randomized study comparing monopolar with bipolar transurethral resection of prostate in benign prostatic obstruction: 36-month outcomes.
Al-Rawashdah SF; Pastore AL; Salhi YA; Fuschi A; Petrozza V; Maurizi A; Illiano E; Costantini E; Palleschi G; Carbone A
World J Urol; 2017 Oct; 35(10):1595-1601. PubMed ID: 28243790
[TBL] [Abstract][Full Text] [Related]
47. The 12-year symptomatic outcome of transurethral resection of the prostate for patients with lower urinary tract symptoms suggestive of benign prostatic obstruction compared to the urodynamic findings before surgery.
Masumori N; Furuya R; Tanaka Y; Furuya S; Ogura H; Tsukamoto T
BJU Int; 2010 May; 105(10):1429-33. PubMed ID: 19863522
[TBL] [Abstract][Full Text] [Related]
48. [Application value of diagnostic TURP for patients with serum PSA abnormality].
Yuan J; Zhao H; Wu B
Zhonghua Nan Ke Xue; 2013 Nov; 19(11):999-1002. PubMed ID: 24341094
[TBL] [Abstract][Full Text] [Related]
49. Evaluation of the transurethral ethanol ablation of the prostate (TEAP) for symptomatic benign prostatic hyperplasia (BPH): a European multi-center evaluation.
Grise P; Plante M; Palmer J; Martinez-Sagarra J; Hernandez C; Schettini M; Gonzalez-Martin M; Castiñeiras J; Ballanger P; Teillac P; Rolo F; Baena V; Erdmann J; Mirone V
Eur Urol; 2004 Oct; 46(4):496-501; discussion 501-2. PubMed ID: 15363567
[TBL] [Abstract][Full Text] [Related]
50. Change in urinary symptoms and quality of life in men with benign prostatic hyperplasia after transurethral resection of prostate.
Chalise PR; Agrawal CS
Nepal Med Coll J; 2007 Dec; 9(4):255-8. PubMed ID: 18298015
[TBL] [Abstract][Full Text] [Related]
51. Risk of urinary incontinence following post-brachytherapy transurethral resection of the prostate and correlation with clinical and treatment parameters.
Mock S; Leapman M; Stock RG; Hall SJ; Stone NN
J Urol; 2013 Nov; 190(5):1805-10. PubMed ID: 23669568
[TBL] [Abstract][Full Text] [Related]
52. Benign prostatic hyperplasia: mode of presentation and postoperative outcome.
Khan M; Khan AL; Khan S; Nawaz H
J Pak Med Assoc; 2005 Jan; 55(1):20-3. PubMed ID: 15816691
[TBL] [Abstract][Full Text] [Related]
53. Examining the 'gold standard': a comparative critical analysis of three consecutive decades of monopolar transurethral resection of the prostate (TURP) outcomes.
Mayer EK; Kroeze SG; Chopra S; Bottle A; Patel A
BJU Int; 2012 Dec; 110(11):1595-601. PubMed ID: 22540956
[TBL] [Abstract][Full Text] [Related]
54. Is the short-term outcome of transurethral resection of the prostate affected by preoperative degree of bladder outlet obstruction, status of detrusor contractility or detrusor overactivity?
Tanaka Y; Masumori N; Itoh N; Furuya S; Ogura H; Tsukamoto T
Int J Urol; 2006 Nov; 13(11):1398-404. PubMed ID: 17083391
[TBL] [Abstract][Full Text] [Related]
55. Durability and cost-effectiveness of transurethral needle ablation of the prostate as an alternative to transurethral resection of the prostate when alpha-adrenergic antagonist therapy fails.
Rosario DJ; Phillips JT; Chapple CR
J Urol; 2007 Mar; 177(3):1047-51; discussion 1051. PubMed ID: 17296409
[TBL] [Abstract][Full Text] [Related]
56. Analysis of bladder vascular resistance before and after prostatic surgery in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction.
Wada N; Watanabe M; Kita M; Matsumoto S; Kakizaki H
Neurourol Urodyn; 2012 Jun; 31(5):659-63. PubMed ID: 22488529
[TBL] [Abstract][Full Text] [Related]
57. [Transurethral resection of the the prostate for lower urinary tract obstruction from advanced prostate cancer].
Fang Y; Ye D; Dai B; Zhang H; Shen Y
Zhonghua Nan Ke Xue; 2004 Nov; 10(11):827-9. PubMed ID: 15595683
[TBL] [Abstract][Full Text] [Related]
58. Palliative transurethral prostate resection for bladder outlet obstruction in patients with locally advanced prostate cancer.
Crain DS; Amling CL; Kane CJ
J Urol; 2004 Feb; 171(2 Pt 1):668-71. PubMed ID: 14713783
[TBL] [Abstract][Full Text] [Related]
59. Delayed diagnosis of prostate cancer with neuroendocrine differentiation after laser TURP.
Meeks JJ; Habermacher GM; Le B; Smith ND
Urology; 2008 Oct; 72(4):948.e11-2. PubMed ID: 18342929
[TBL] [Abstract][Full Text] [Related]
60. Lower Urinary Tract Symptoms Following Transurethral Resection of Prostate.
Kim SJ; Al Hussein Alawamlh O; Chughtai B; Lee RK
Curr Urol Rep; 2018 Aug; 19(10):85. PubMed ID: 30128964
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]